Therapeutic antibodies
from EU-approved medicines

Currently, we offer 23 different therapeutic monoclonal antibodies from EU licensed drugs for use in R&D, preclinical development, process development, manufacturing & clinical development. Research-relevant quantities of the original drug are available as aliquot or dilution.

Drug name	Therapeutic molecule All molecules shown in this table are clinically approved by an international regulatory institution. However, all products sold by Evientic are for analytical / pre-clinical use only. Human use is prohibited! At this time (01/2020) all molecules available from Evidentic are licensed in the EU market.	Antigen	CoA availability What is a CoA? CoA is short for 'Certificate of Analysis' and is issued by the original drug manufacturer for each batch. This document is sometimes supplied with the pharmaceutical product. Customers can purchase the available CoA for an additional fee. Legend: yes : CoA for this product are available no : no CoA for each available batch no / yes: for most/some batches of a specific product CoA can be obtained from Evidentic.
Avastin	Bevacizumab	VEGF-A	no ⋅ yes	Select options
Bavencio	Avelumab	PD-L1	no	Select options
Cosentyx	Secukinumab	IL 17A	no ⋅	Select options
Cyramza	Ramucirumab	VEGFR2	no	Select options
Darzalex	Daratumumab	CD38	no	Select options
Enbrel	Etanercept	TNF-α	no	Select options
Erbitux	Cetuximab	EGFR	no	Select options
Gazyvaro	Obinutuzumab	CD20	no	Select options
Herceptin	Trastuzumab	HER2	no	Select options
Humira	Adalimumab	TNF-α	no ⋅ yes	Select options
Imfinzi	Durvalumab	PD-L1	no	Select options
Keytruda	Pembrolizumab	PD-1	no ⋅ yes	Select options
Mabthera	Rituximab	CD20	no	Select options
Opdivo	Nivolumab	PD-1	no	Select options
Perjeta^new	Pertuzumab	HER2	no ⋅ yes	Select options
Prolia	Denosumab	RANKL	no	Select options
Remicade	Infliximab	TNF-α	no	Select options
RoActemra	Tocilizumab	IL-6 R	no	Select options
Simponi	Golimumab	TNF-α	no	Select options
Stelara	Ustekinumab	IL-12	no	Select options
Synagis	Palivizumab	RSV protein F	no ⋅ yes	Select options
Tecentriq^new	Atezolizumab	PD-L1	yes	Select options
Yervoy^new	Ipilimumab	CD152 ⋅ CTLA4	no ⋅ yes	Select options

Showing 1–12 of 42 results

Therapeutic antibodies
from EU-approved medicines

Synagis / Palivizumab diluted

Stelara / Ustekinumab diluted

Remicade / Infliximab diluted

RoActemra / Tocilizumab diluted

Prolia / Denosumab diluted

Simponi / Golimumab diluted

Opdivo / Nivolumab diluted

MabThera / Rituximab diluted

Keytruda / Pembrolizumab diluted

Humira / Adalimumab diluted

Herceptin /Trastuzumab diluted

Gazyvaro / Obinutuzumab diluted

Signup for news and special offers!